Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
UBS Boosts Boston Scientific (BSX) Price Target After Strong Q3 Earnings
Boston Scientific Corporation (NYSE:BSX) ranks among the best long-term stocks to buy according to D. E. Shaw. On October 23, UBS maintained its Buy rating on Boston Scientific Corporation (NYSE:BSX) ... Read More
Boston Scientific Shares Surge on Exceptional Quarterly Performance
The medical technology sector is witnessing remarkable momentum as Boston Scientific delivers a stunning third-quarter report for 2025. While the financial r ... Read More
Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
On Wednesday, Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion, beating the consensus estimate of $4.97 billion. The medical technology giant reported ... Read More
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
The Boston Scientific Analyst: Analyst David Roman reiterated a Buy rating and price target of $120. The Boston Scientific Thesis: The company's total sales grew 20.3% year-on-year to around $5.1 ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus